![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2420 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Janson, Amélie (Excelya 202007 Communications Director) | Public Relations Manager / Investor Relations Manager | Excelya (Group) | Île-de-France (region) |
| Janson, Amélie (Voluntis 201912 Public Relations) | Public Relations Manager / Investor Relations Manager | Voluntis (Group) | Île-de-France (region) |
| Janssens, Koen (Applied Maths 201305 CEO) | Chief Executive Officer (CEO) | Mérieux (Group) | Belgium_o |
| Jaskowiak, John (ExonHit 200609– Exec VP Business + Marketing before Affymetrix SenDirector Marketing before Agilent) | Sales Manager / Marketing Manager | Eurobio Scientific (Group) | Maryland (federal state) |
| Jaulin, Fanny (Orakl Oncology 202310 CEO + CSO + Co-Founder) | Chief Executive Officer (CEO) | Orakl Oncology SAS | Île-de-France (region) |
| Javaud, Christophe (Gustave Roussy 202111 COO) | Chief Operating Officer (COO) | Gustave Roussy (Group) | Île-de-France (region) |
| Jean, Christophe (Ipsen –200708– Executive VP + COO) | Chief Operating Officer (COO) | Ipsen (Group) | Île-de-France (region) |
| Jean, Thierry (Cerep 200905 Chairman + CEO) | Chief Executive Officer (CEO) | Eurofins (Group) | France (region/state unspecified) |
| Jeanne, Albin (Apmonia Therapeutics 202202 President + Co-Founder) | President/Director/Head Business Group/Unit/Division | Apmonia Therapeutics SAS | Grand Est (Great East) (region) |
| Jeddeloh, Jeffrey A. (DNA Script 201811– VP BusDev + Commercial Strategy before Roche + Orion Genomics) | Business Development Manager / Strategy Manager | DNA Script (Group) | California (federal state) |
| Jeggo, Ross (Servier 202101 Head of Neurology + Immuno-inflammation Therapeutic Area) | President/Director/Head Business Group/Unit/Division | Servier (Group) | Île-de-France (region) |
| Jégu, Stéphanie (Diabeloop 201912 Press Contact) | Public Relations Manager / Investor Relations Manager | Diabeloop S.A. | Auvergne-Rhône-Alpes (region) |
| Jehle, Regina (Abivax 201912– Director of Communications before BioNTech 2014– 2019) | Public Relations Manager / Investor Relations Manager | Abivax (Group) | Île-de-France (region) |
| Jell, Jason (Sartorius 202110 Head of Marketing Communications Bioprocessing Division) | Public Relations Manager / Investor Relations Manager | Sartorius (Group) | Niedersachsen (federal state) |
| Jemai, Sarah (Stilla Technologies 201811 Marketing Manager) | Sales Manager / Marketing Manager | Stilla Technologies (Group) | Île-de-France (region) |
| Jenn, Stephan (Novalix 201011 President) | President/Director/Head Business Group/Unit/Division | Novalix (Group) | Grand Est (Great East) (region) |
| Jennings, Bryan (Noxxon 202111– CFO before Peptilogics + KAHR Bio + Beren Tx + Vista Capital Advisors + Morgan Stanley) | Chief Financial Officer (CFO) | TME Pharma (Group) | North Holland (province, NL) |
| Jensen, Johannes (Novo Group 200501 VP of Novo Nordisk Biotech Fund) | Investment Manager | Novo Group (Group) | Denmark_o |
| Jeong, Ryan (Mirae Asset 202106 at Mirae Asset Capital) | Investment Manager | Mirae Asset (Group) | Korea, Republic of (state/region unspecified) |
| Jessup, Judd (AviaraDx 200607– before US Labs) | n. a. | Hologic (Group) | California (federal state) |
| Ji, Henry (Sorrento Therapeutics 201607 CEO) | Chief Executive Officer (CEO) | Sorrento Therapeutics (Group) | California (federal state) |
| Joannes, Nathalie (Ipsen 201110– EVP General Counsel before Genzyme BV + Monsanto + Serono) | General Counsel / Chief Legal Officer (CLO) | Ipsen (Group) | Île-de-France (region) |
| Johnson, Robert (Rob) (Alacrita 2009– Founding Partner before Onyvax Head Business Development) | Company Founder | Alacrita (Group) | Greater London (region) |
| Johnson, Tim (TJ) (High Throughput Genomics 200811 CEO before Ventana Medical) | Chief Executive Officer (CEO) | Codetta Bio Inc. (Codetta Biosciences) | North Carolina (federal state) |
| Johnson, Todd (Accelrys 201004– EVP Sales, Marketing + Services before 200901– interim CEO before Kontiki) | Sales Manager / Marketing Manager | Dassault Systèmes (3DS) (Group) | California (federal state) |
| Joly, Nadège (GIE Eurasanté 201708) | n. a. | GIE Eurasanté | Hauts-de-France (Upper France) (region) |
| Jones, Elizabeth (Acambis 199604– CFO) | Chief Financial Officer (CFO) | Sanofi (Group) [since May 2011] | East of England (region) |
| Jones, Frank (Schlumberger 200305 + InforSense Board Director 200305–) | Board member, non-executive | Schlumberger (Group) | Île-de-France (region) |
| Jones, Rachel (Idaho Technology 201009 VP Marketing + Sales) | Sales Manager / Marketing Manager | Mérieux (Group) | Utah (federal state) |
| Jordan, Pablo (Definiens 201310– VP Business Development Clinical Digital Pathology before bioMérieux + Ventana) | Business Development Manager / Strategy Manager | AstraZeneca (Group) | Bayern (federal state) |
| Jouve, Alexandre (Theodorus 202112 Principal) | Principal (venture capital) | Theodorus (Group) | Brussels (region) |
| Judde, Jean-Gabriel (XenTech 201402 CSO + Co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | XenTech SAS | Île-de-France (region) |
| Judice, J. Kevin (DiCE Molecules 202101 CEO formerly Achaogen 200610 CSO) | Chief Executive Officer (CEO) | Eli Lilly (Group) | California (federal state) |
| Jungbauer, Alois (Austrian Centre of Industrial Biotechnology) | Professor | ACIB GmbH – Austrian Centre of Industrial Biotechnology | Steiermark (Styria) |
| Just Larsen, Philip (Grünenthal 201804– CSO before Sanofi Ffm + Eli Lilly + Novo Nordisk) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Grünenthal (Group) | Nordrhein-Westfalen (federal state) |
| Juuel, Henrik (Bavarian Nordic 201811– before Orexo + Virgin Mobile + GN ReSound + NNE Pharmaplan + Novo Nordisk) | Chief Financial Officer (CFO) | Bavarian Nordic (Group) | Denmark_o |
| Kaczorek, Michel (Synt:em 200211 CEO) | Chief Executive Officer (CEO) | Synt:em S.A. | France (region/state unspecified) |
| Kadaba, Neena (Quark Venture 202001 Director of Science) | n. a. | Quark Venture L.P. | British Columbia |
| Kalkbrenner, Frank (Boehringer 201308 CVP + Head of BIVF + CEO Acousia Therapeutics GmbH) | Investment Manager | Boehringer Ingelheim (Group) | Rheinland-Pfalz (federal state) |
| Kamkolkar, Milind (Cellarity 201912– Chief Digital + Data Officer before Sanofi + Novartis) | n. a. | Cellarity Inc. | Massachusetts (federal state) |
| Kandera, Reinhard (Hookipa Biotech 201704– CFO before Valneva CFO + Intercell CFO + Deutsche Bank AG) | Chief Financial Officer (CFO) | Hookipa (Group) | Wien (state) |
| Kane, Matthew (Matt) (Precision BioSciences 200803–202110 CEO + Co-Founder) | Chief Executive Officer (CEO) | Precision BioSciences (Group) | North Carolina (federal state) |
| Kang, Y. S. (Lab Frontier (KR) 201804 CEO) | Chief Executive Officer (CEO) | Eurofins (Group) | Korea, Republic of (state/region unspecified) |
| Karako, Marc (Quantum Genomics 201811 CFO) | Chief Financial Officer (CFO) | Quantum Genomics (FR) (Group) | Île-de-France (region) |
| Kaspar, Peter (bioMérieux 200609 Head of RnD) | n. a. | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Kasunich, Caitlin (KSCA Strategic Communications 201706) | Public Relations Manager / Investor Relations Manager | KCSA Strategic Communications | New York (federal state) |
| Kaufhold, Achim (Basilea 201211 CMO before Affitech A/S + Pharmexa + Chiron + Berna Biotech + GSK) | Chief Medical Officer (CMO) | Pharmexa (Group) | Denmark_o |
| Kaul, Samir (Khosla Ventures 201709 Partener) | Partner (venture partner) | Khosla Ventures | California (federal state) |
| Kay, Andrew (NuCana 202012– Board Chairman also at Boards of NeRRe Tx + Blueberry Tx former CEO of Algeta) | Board member, non-executive | NuCana plc (Nasdaq: NCNA) | Scotland |
| Kehren, Jeanne (Bayer 202008 Head of Digital + Commercial Innovation + Member of Pharma Executive Committee) | President/Director/Head Business Group/Unit/Division | Bayer (Group) | Berlin (federal state) |
| Kelley, Chris (Norstella 202402 Chief Revenue Officer at Evaluate) | Sales Manager / Marketing Manager | Norstella (MMIT / Managed Markets Insight & Technology) (Group) | Greater London (region) |
| Kempf, Adeline (France (govt) 201804 at Bpifrance) | n. a. | France (govt) | Île-de-France (region) |
| Kempf, Agnès (Andrew Lloyd & Associates 201509) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | South East England (region) |
| Kemps, Serge (Nipro 201601 at Nipro Europe) | n. a. | Nipro Corporation (Group) | |
| Kemula, Pierre (CureVac 201610– CFO before Pixium Vision + Ipsen + Roland Berger) | Chief Financial Officer (CFO) | CureVac (Group) | Baden-Württemberg (federal state) |
| Kenneweg, John (908 Devices 201503 VP Sales) | Sales Manager / Marketing Manager | 908 Devices (Group) | Massachusetts (federal state) |
| Kenny, Daniel (Abivax 201410– COO + VP Business Development before Baxter Vaccines + Baxter BioScience) | Chief Operating Officer (COO) | Abivax (Group) | Île-de-France (region) |
| Kerbarh, Olivier (Eligo Bioscience 201909– Senior Manager CMC before DBV Technologies + Endotis Pharma) | management (personnel) | Eligo Bioscience S.A. | Île-de-France (region) |
| Kersting, Michael (Vilder 201405 Managing Director of Vilbar Lourmat Deutschland GmbH) | Managing Director | Vilber (Group) | Baden-Württemberg (federal state) |
| Kertesz, Vilmos (United States (govt) 201601 at Oak Ridge National Laboratory) | Researcher (university / research institute) | United States (govt) | Virginia (federal state) |
| Kerveillant, Anne (Pierre Fabre 202110 Communication Manager) | Public Relations Manager / Investor Relations Manager | Pierre Fabre (Group) | Île-de-France (region) |
| Khalique, Saffiyah (Andrew Lloyd Associates 202205) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | South East England (region) |
| Khan, Shobi (Canary Wharf Group 202203 CEO) | Chief Executive Officer (CEO) | Canary Wharf Group (CWG) | Greater London (region) |
| Khinouche, Karim-Franck (Novolyze 201801 CEO + Founder) | Chief Executive Officer (CEO) | Novolyze (Group) | Bourgogne-Franche-Comté (Burgundy-Free County) (region) |
| Kieback, Elisa (T-Knife 202101 CTO before 201711– Managing Director + Co-Founder) | Chief Technology/Technical Officer (CTO) | T-Knife (Group) | Berlin (federal state) |
| Kim, Hyun Tae (Mirae Asset 201810 General Manager + Head Bio Investment Team at Miare Asset Capital) | General Manager (management) | Mirae Asset (Group) | Korea, Republic of (state/region unspecified) |
| Kim, J. Joseph (Inovio 200906 CEO before VGX Pharmaceuticals 200807 CEO + co-founder) | Chief Executive Officer (CEO) | Inovio (Group) | California (federal state) |
| Kinkingnéhun, Serge (EyeBrain 201304 CEO) | Chief Executive Officer (CEO) | EyeBrain (FR) | Île-de-France (region) |
| Kirchhoff, Petra (Sartorius 201401 VP Group Corporate Communications + IR) | Public Relations Manager / Investor Relations Manager | Sartorius (Group) | Niedersachsen (federal state) |
| Kirschbaum, Bernhard (Merck Serono 200809 Executive VP Research) | Research & Development Manager | Merck (DE) (Group) | Hessen (Hesse) (federal state) |
| Kirst, Oliver (Servier 201711 General Manager of Servier Germany) | General Manager (management) | Servier (Group) | Bayern (federal state) |
| Kitten, Olivier (Affilogic 201508 CEO) | Chief Executive Officer (CEO) | Affilogic SAS | Pays de la Loire (region) |
| Klausner, Richard (Rick) (Lyell Immunopharma 201910 CEO + Founder before Juno Therapeutics + NCI) | Chief Executive Officer (CEO) | Lyell Immunopharma, Inc. | California (federal state) |
| Klein, Justin (Vensana Capital 202301 Managing Partner + Co-Founder) | Managing Partner (investment firm) | Vensana Capital (US) | United States (USA)_o |
| Kleinman, Scott (Apollo Global Management 202205 Co-President) | President/Director/Head Business Group/Unit/Division | Apollo Global Management (Group) | New York (federal state) |
| Kliegl, Julie (Eurofins 201508 President of Viracor-IBT Laboratories Inc) | President/Director/Head Business Group/Unit/Division | Eurofins (Group) | Missouri (federal state) |
| Kliphuis, Edward (Sofinnova Partners 202402 Partner before Amadeus Capital + M Ventures + Kempen & Co) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
| Klæbel, Nille (Atlas Antibodies 202109– CEO before Philips Nordics + GSK + Sanofi + Novo Nordisk) | Chief Executive Officer (CEO) | Atlas Antibodies (Group) | Stockholm (region) |
| Knight, Robin (In-Part 202202 Director + Co-Founder) | President/Director/Head Business Group/Unit/Division | Inpart (Group) | Yorkshire and the Humber (region) |
| Kniss, Richard D. (Agilent until 2001 Arcturus Board 200503) | n. a. | Hologic (Group) | California (federal state) |
| Knopp, Kevin J. (908 Devices 201303 CEO + Co-founder before Thermo Fisher + Ahura Scientific) | Chief Executive Officer (CEO) | 908 Devices (Group) | Massachusetts (federal state) |
| Kobler, Johanna (MC Services 202210) | Public Relations Manager / Investor Relations Manager | MC Services AG | Bayern (federal state) |
| Koch, Martin (Genticel 201507– interim CEO before CFO) | Chief Financial Officer (CFO) | Calliditas Therapeutics (Group) | Occitanie (Occitania) (region) |
| Koehler, Uwe (Eurofins 201603 Head Gene Synthesis + Molecular Biology at Eurofins Genomics) | President/Director/Head Business Group/Unit/Division | Eurofins (Group) | Bayern (federal state) |
| Koenig, Scott (MacroGenics 200109– became SVP 5/06 is CEO before MedImmune) | Chief Executive Officer (CEO) | MacroGenics (Group) | Maryland (federal state) |
| Kohlberg, Isaac T. (Harvard Univ 201710 Senior Associate Provost + Chief Technology Development Officer) | IP Manager | Harvard University | Massachusetts (federal state) |
| Kola, Ismail (UCB 201111 President of UCB New Medicines) | President/Director/Head Business Group/Unit/Division | UCB (Group) | Brussels (region) |
| Kolam, Hans (Active Biotech 201208 CFO) | Chief Financial Officer (CFO) | Active Biotech (Group) | Skåne |
| Koremans, Robert (Rob) (EUSA Pharma 202112 CEO formerly Teva Europe + Sanofi-Aventis + Cryo-Save + Serono + Sanofi) | Chief Executive Officer (CEO) | Recordati (Group) | United Kingdom (state/region unspecified) |
| Korman, Patrick (Myriad Genetics 201508 CEO in France + France Biotech 201508 Board Member) | Chief Executive Officer (CEO) | Myriad Genetics SAS | Île-de-France (region) |
| Kornowski-Bonnet, Sophie (Roche 201202–201807 Head of Roche Partnering before Roche Pharma France LEFT 7/18) | Business Development Manager / Strategy Manager | Roche (Group) | Northwestern Switzerland (region) |
| Kosciusko-Morizet, Nathalie (France (govt) 200808 Secretary of State) | n. a. | France (govt) | Île-de-France (region) |
| Kosmatopoulos, Kostas (Vaxon Biotech 201412 CSO + Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Vaxon Biotech S.A. | Île-de-France (region) |
| Koss, Ashleigh (Gilead Sciences 202402 Media Relations formerly Sanofi 202009 VP Head of Global Media Relations) | Public Relations Manager / Investor Relations Manager | Gilead Sciences (Group) | California (federal state) |
| Kottke, Andrea (Antisense Pharma 201207 Head Marketing + Public Relations) | Sales Manager / Marketing Manager | Isarna Therapeutics GmbH | Bayern (federal state) |
| Kourilsky, Philippe (A*STAR 201008 Chairm SIgN) | n. a. | Singapore (govt) | Singapore (cl=4) |
| Kowalsky, Matthew (Matt) (Sigilon Therapeutics 201906– SVP + General Counsel before Proteon Tx + Sanofi Genzyme) | General Counsel / Chief Legal Officer (CLO) | Eli Lilly (Group) | Massachusetts (federal state) |
| Krel, Michael (Sofinnova 201703– Principal at Sofinnova IB I) | Principal (venture capital) | Sofinnova (Group) | Île-de-France (region) |
| Kreuzburg, Joachim (Sartorius 200305– CEO) | Chief Executive Officer (CEO) | Sartorius (Group) | Niedersachsen (federal state) |
| Krishnan, Shiv (Sanofi 201810 Head of Technology Platforms, Global BusDev + Licensing) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
